1Hsu HC, Lee YM, Tsai WH, et al. Circulating levels of thmmbopoietie and inflammatory cytokines in patients with acute myeloblaatie leukemia and myeledysplastie syndrome[J]. Oncology, 2002,63:64-69. 被引量：1
2Enright H,Miller W.Autoimmune phenomena in patients with myelodysplastic syndromes[J].Ituk Lymphoma,1997,24:483-489. 被引量：1
3Enright H, Jacob HS, Vercellotti G, et al. Paraneoplastie autoimmune phenomena in patients with myelodysplastie syndromes: response to 403-408. e therapy[J]. Br J Haematol, 1995,91. 被引量：1
4Castro M, Conn DL, Su W'P, et al. Rheumatic manifestations in myelodysplastic syndromes[J]. J Rheumatol, 1991,18:721-727. 被引量：1
5Okamoto T, Okada M, Mori A, et al. Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients[J]. Int J Hematol, 1997,66:345-351. 被引量：1
7Giannouli S, Voulgarelis M, Zintzaras E, et al. Autoimmune phenomena in myelodysplastie syndromes:a 4 -- yr prospective study[J]. Rheumatology, 2004,43:626-632. 被引量：1
8Yamato K. Successful cord blood stem cell transplantation for myelodysplastic syndrome with Behget disease[J], hat J Hematol, 2003,77:82-85. 被引量：1
二级参考文献7
1Mufti GJ, Figes A, Hamblin TJ, et al. Immunological abnormalities in myelodysplastic syndromes. Br J Haematol, 1986, 63: 143- 147. 被引量：1
2Nam EJ, Kang YM, Kang HR, et al. Rheumatoid arthritis associated with myelodysplastic syndrome: a case report. J Korean Med Sci, 1999, 14: 319-322. 被引量：1
3Castro M, Conn DL, Su WP, et al. Rheumatic manifestation in myelodysplastic syndromes. J Rheumatol, 1991, 18: 721-727. 被引量：1
4Hamidou MA, Derenne S, Audrain MAP, et al. Prevalence of rheumatic manifestations and antineutrophil cytoplasmic antibodies in haematological malignancies: a prospective study. Rheumatology, 2000, 39: 417-420. 被引量：1
5Enrlght H, Miller W. Autoimmune phenomena in patients with myelodysplastic syndromes. Leuk Lymphoma, 1997, 24: 483-489. 被引量：1
6Naschitz JE, Rosner I, Rozenbaum M, et al. Cancer-associated rheumatic disorders. Semin Arthritis Rheum, 1995, 24: 231-241. 被引量：1
